What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Enzyme
His primary areas of study are Internal medicine, Endocrinology, Immunology, RAGE and Receptor.
His research integrates issues of Endothelial stem cell and Type 2 diabetes in his study of Internal medicine.
As part of his studies on Endocrinology, Peter P. Nawroth frequently links adjacent subjects like Transcription factor.
His work carried out in the field of Immunology brings together such families of science as Integrin, Ischemia and Cell biology.
The study incorporates disciplines such as Cell activation and Diabetic angiopathy in addition to RAGE.
His Receptor research is multidisciplinary, relying on both In vitro and Signal transduction.
His most cited work include:
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease (1751 citations)
- RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. (1596 citations)
- Modulation of endothelial cell hemostatic properties by tumor necrosis factor. (1139 citations)
What are the main themes of his work throughout his whole career to date?
Peter P. Nawroth focuses on Internal medicine, Endocrinology, Diabetes mellitus, Cell biology and Immunology.
His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology and Type 2 diabetes.
Many of his studies involve connections with topics such as Methylglyoxal and Endocrinology.
Peter P. Nawroth has included themes like Surgery and Bioinformatics in his Diabetes mellitus study.
Peter P. Nawroth studied Cell biology and Endothelial stem cell that intersect with Tumor necrosis factor alpha and Thrombomodulin.
His Immunology research integrates issues from RAGE and Tissue factor.
He most often published in these fields:
- Internal medicine (51.92%)
- Endocrinology (42.18%)
- Diabetes mellitus (23.16%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (51.92%)
- Diabetes mellitus (23.16%)
- Endocrinology (42.18%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Diabetes mellitus, Endocrinology, Methylglyoxal and Type 2 diabetes.
His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology, Nephropathy and Type 2 Diabetes Mellitus.
His studies in Diabetes mellitus integrate themes in fields like Neuropathic pain, Surgery and Bioinformatics.
His Endocrinology research incorporates elements of Reactive oxygen species and Zebrafish.
His Methylglyoxal study integrates concerns from other disciplines, such as Glycation, Metabolism and Detoxification.
His study in Glycation focuses on RAGE in particular.
Between 2015 and 2021, his most popular works were:
- Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice (116 citations)
- Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study. (98 citations)
- Dicarbonyls and Advanced Glycation End-Products in the Development of Diabetic Complications and Targets for Intervention. (67 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Enzyme
His main research concerns Internal medicine, Endocrinology, Methylglyoxal, Diabetes mellitus and Type 2 diabetes.
His Internal medicine study which covers Gastroenterology that intersects with Comorbidity.
His studies deal with areas such as Signal transduction and Tauroursodeoxycholic acid as well as Endocrinology.
His Methylglyoxal research includes themes of Glycation and Detoxification.
His research on Glycation focuses in particular on RAGE.
His work deals with themes such as Receptor, Angiotensin II and Renin–angiotensin system, which intersect with Diabetes mellitus.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
